GlassScriptPhysician profile
Kevin Sagers
NPI 1194102657
$29,910.27
in general payments reported to CMS, 2019-2025
21 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2020: $11K · 2021: $12K · 2022: $1,911 · 2023: $2,650 · 2024: $709 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,385 · Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,384.80 |
| Food and Beverage | $1,146.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $25,135.62 | 2019-2024 | Real Intelligence, Evos, Trigen Intertan |
| Ortho Development Corporation | $2,471.15 | 2023 | |
| Goode Surgical INC | $717.29 | 2019 | |
| Stryker Corporation | $480.88 | 2019-2024 | Insignia, Mako |
| Think Surgical, INC. | $207.20 | 2024 | |
| Medtronic USA, INC. | $139.99 | 2019 | |
| Organogenesis INC. | $132.56 | 2020 | |
| Kci USA, INC. | $100.32 | 2019 | |
| Depuy Synthes Sales INC. | $76.83 | 2021 | |
| Boston Scientific Corporation | $71.03 | 2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $62.25 | 2023 | Iovera |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Zimmer Biomet Holdings, INC. | $58.15 | 2025 | Totalshield |
| Microport Orthopedics INC | $33.42 | 2019 | |
| Solventum Corporation | $29.60 | 2024 | Prevena Restor Arthroform |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $26.36 | 2020 | |
| Innovation Technologies INC | $26.08 | 2025 | Irrisept |
| Amgen INC. | $25.83 | 2023 | Prolia |
| Nevro Corp. | $20.70 | 2019 | |
| Abbvie INC. | $18.92 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Sagers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.